MoneyAM MoneyAM
 Home   Log In   Register   Our Services   My Account   Contact   Help 
 Stockwatch   Level 2   Portfolio   Charts   Research   Share Price   Awards   Indices   Market Scan   Company Zone   Traders' Room 
 Funds   Trades   Terminal   Alerts   Heatmaps   News   Stock Screener   Forward Diary   Forex Prices   Director Deals   Investors' Room 
 CFDs   Shares   SIPPs   ISAs   Forex   ETFs   Videos   Comparison Tables   Spread Betting   Broker Notes   Shares Magazine 
You are NOT currently logged in

Filter Criteria  
Epic: Keywords: 
From: Time:  (hh:mm) RNS:  MonAM: 
To: Time:  (hh:mm)
Please Note - Streaming News is only available to subscribers to the Active Level and above

Premaitha Health revenue up 45% in first half

Molecular diagnostics group Premaitha Health said its revenue in the first half grew by 45% to around £3.9m.

Premaitha also said it had made a 'strong start' to the second half.

All required legal settlement actions relating to patent infringement court proceedings had now been completed, it added.

'I am pleased to report strong sales growth in the first half of the financial year and that this momentum has continued into the second half,' chief executive Lyn Rees said.

'With the intellectual property litigation now behind us, the company is focused on capitalising on its global opportunity and driving growth.'

Story provided by